Quality of Life in Abdominal Cancer Patients

What we are studying

The purpose of this study is to learn more about the quality of life of individuals prior to and up to 2 years following Intraperitoneal Hyperthermic Chemotherapy (IPHC) for abdominal cancer (Peritoneal Carcinomatosis). This information may be useful to patients considering IPHC and will be used in future work with these patients.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Diagnosed with abdominal cancer (Peritoneal Carcinomatosis)

What is involved

  • Participation will last about 24 months
  • Study activities include 9 surveys over 5 study visits

Compensation

None

Contact Information

Study Coordinator
Joyce Fenstermaker, RN
Email
jfenster@wakehealth.edu
Phone
336-713-3155

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.